Last update 02 Nov 2024

YKST02

Overview

Basic Info

Drug Type
Bispecific T-cell Engager (BiTE)
Synonyms
YKST02
Target
BCMA x CD3
Mechanism
BCMA inhibitors(B-cell maturation protein inhibitors), CD3 stimulants(T cell surface glycoprotein CD3 stimulants)
Therapeutic Areas
NeoplasmsImmune System DiseasesCardiovascular Diseases+ [2]
Active Indication
Plasma cell myeloma refractoryGlomerulonephritis, IGA
Inactive Indication-
Originator Organization
Excyte Biopharma LtdExcyte Biopharma Ltd
Active Organization
Excyte Biopharma LtdExcyte Biopharma Ltd
Inactive Organization-
Drug Highest PhasePhase 1
First Approval Date-
Regulation-
Login to view timeline

Related

2
Clinical Trials associated with YKST02
NCT06574568 / RecruitingPhase 1
A Multicenter, Open-label, Phase I Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Preliminary Antitumor Efficacy of YKST02 in Participants with Relapsed or Refractory Multiple Myeloma
CTR20241570 / RecruitingPhase 1
评价YKST02治疗复发/难治性多发性骨髓瘤的安全性、耐受性、药代动力学特征和初步抗肿瘤疗效的多中心、开放性、I期临床研究
[Translation] A multicenter, open-label, phase I clinical study to evaluate the safety, tolerability, pharmacokinetic characteristics and preliminary anti-tumor efficacy of YKST02 in the treatment of relapsed/refractory multiple myeloma
100 Clinical Results associated with YKST02
Login to view more data
100 Translational Medicine associated with YKST02
Login to view more data
100 Patents (Medical) associated with YKST02
Login to view more data
100 Deals associated with YKST02
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Plasma cell myeloma refractoryPhase 1
CN
Excyte Biopharma LtdExcyte Biopharma Ltd
14 Jun 2024
Glomerulonephritis, IGAPreclinical
CN
Excyte Biopharma LtdExcyte Biopharma Ltd
01 Oct 2024
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free